<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03185936</url>
  </required_header>
  <id_info>
    <org_study_id>ODP-M</org_study_id>
    <nct_id>NCT03185936</nct_id>
  </id_info>
  <brief_title>Surgical Management of Optic Disc Pit Maculaopathy</brief_title>
  <official_title>Pars Plana Vitrectomy With Internal Limiting Membrane Peeling in Optic Disc Pit Maculopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the anatomical and functional results of pars plana vitrectomy (PPV) combined
      with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade
      in management of optic disc pit (ODP) maculopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As it is well known, optic disc pit (ODP) is a rare congenital disease which is usually
      associated with maculopathy (ODP-M) in the form of intraretinal and subretinal fluid
      accumulation at the macular area leading to visual impairment.

      With no definite treatment and absence of guidelines for its management, the invistigators
      considered their prospective, interventional case series to evaluate the anatomical and
      functional results of pars plana vitrectomy (PPV) combined with internal limiting membrane
      (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit
      (ODP) maculopathy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2011</start_date>
  <completion_date type="Actual">April 1, 2017</completion_date>
  <primary_completion_date type="Actual">April 1, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>anatomical improvement</measure>
    <time_frame>6 months</time_frame>
    <description>Retinal reattachment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional improvement</measure>
    <time_frame>6 months</time_frame>
    <description>Visual acuity letters gain</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Optic Disc Structural Anomaly</condition>
  <condition>Maculopathy</condition>
  <arm_group>
    <arm_group_label>Optic disc pit maculopathy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>pars plana vitrectomy with internal limiting membrane (ILM) peeling, endolaser</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pars plana vitrectomy with internal limiting membrane (ILM) peeling</intervention_name>
    <description>pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.</description>
    <arm_group_label>Optic disc pit maculopathy</arm_group_label>
    <other_name>Endolaser photocoagulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients included in this study are those with ODP associated with macular detachment

        Exclusion Criteria:

          -  Exclusion criteria included patients unfit for general anesthesia, those with
             insufficient clear media to perform the surgery with ILM peeling and those with other
             ocular diseases that can affect central macular thickness (CMT) and the best corrected
             visual acuity (BCVA).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmud Genaidy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor of ophthalmology, ophthalmology department, Minia university, Egypt</affiliation>
  </overall_official>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2017</study_first_submitted>
  <study_first_submitted_qc>June 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2017</study_first_posted>
  <last_update_submitted>June 9, 2017</last_update_submitted>
  <last_update_submitted_qc>June 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Mahmoud Genaidy</investigator_full_name>
    <investigator_title>Assistant professor of ophthalmology</investigator_title>
  </responsible_party>
  <keyword>optic disc pit</keyword>
  <keyword>retinal detachment</keyword>
  <keyword>maculopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Abnormalities</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Temazepam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Can not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

